Sphinx Pharma deal

Sphinx Pharmaceuticals Corp. (SPHX) Eli Lilly and Co. completed its previously announced acquisition of SPHX for $6 per share. SPHX has 12.6 million shares. SPHX will be operated as a division of Lil...